Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN): 12-Month Outcomes and Quality of Life After Brain Tumor Ablation

Albert H Kim,Steven Tatter,Ganesh Rao,Sujit Prabhu,Clark Chen,Peter Fecci,Veronica Chiang,Kris Smith,Brian J Williams,Alireza M Mohammadi,Kevin Judy,Andrew Sloan,Zulma Tovar-Spinoza,James Baumgartner,Constantinos Hadjipanayis,Eric C Leuthardt
DOI: https://doi.org/10.1093/neuros/nyaa071
IF: 5.315
2020-04-21
Neurosurgery
Abstract:Laser interstitial thermal therapy (LITT) with magnetic resonance imaging (MRI) guidance has been used for more than 10 yr to treat patients with glioblastoma (GBM), brain metastases, gliomas, radiation necrosis, and epilepsy.1 Since 2015, over 700 patient experiences have been described in peer-reviewed literature of laser ablation or "LITT" for primary and metastatic brain tumors (PubMed search 2019). However, commercial use of LITT is estimated to be over 5000 procedures at approximately 150 sites in the USA.
surgery,clinical neurology
What problem does this paper attempt to address?